Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015 and based in Barcelona, Spain, Capital Cell is an alternative investment platform specializing in biotechnology and life sciences. The firm has a rigorous selection process, investing in only about 3% of the companies that apply. They focus on early-stage investments, primarily in Europe.
Capital Cell invests in pre-seed, seed, and seed-plus stages within the biotechnology and healthcare sectors. The firm seeks opportunities with global scalability and significant impact on human health, emphasizing a rigorous selection process to identify promising companies.
Notable investments by Capital Cell include Oragen (RNA technology for treating intestinal inflammation), AbTx (cancer treatments targeting solid tumors), and DynamicsVR (rehabilitation automation using VR and AI). Other portfolio companies include ALA Diagnostics (rapid diagnostic kit for Multiple Sclerosis) and 2EyesVision (simulations for cataract surgery decisions).
Submit your pitch through their form at capitalcell.com.
Capital Cell typically participates in early-stage rounds, often leading investments in the companies they select.
The firm is open to follow-on investments, particularly for companies that demonstrate significant progress and potential for scalability.
Specific fund size details are not disclosed, but Capital Cell focuses on early-stage investments in the biotech sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.